Sex differences in the vaccine-specific and non-targeted effects of vaccines

Vaccine

Volumn 29, Issue 13, 2011, Pages 2349-2354

  Flanagan, Katie L ^a   Klein, Sabra L ^b   Skakkebaek, Niels E ^c   Marriott, Ian ^d   Marchant, Arnaud ^e   Selin, Liisa ^f   Fish, Eleanor N ^g   Prentice, Andrew M ^h,i   Whittle, Hilton ^a   Benn, Christine Stabell ^j,k   Aaby, Peter ^j,k  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c University of Copenhagen   (Denmark)

^d UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h MEDICAL RESEARCH COUNCIL   (United Kingdom)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^j STATENS SERUM INSTITUT   (Denmark)

^k Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

more..

Author keywords

Adaptive immunity; Heterologous immunity; Innate immunity; Non specific effects; Non targeted effects; Reactogenicity; Sex differences; Sex hormones; Vaccines; Vitamin A; X linked genes

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES VACCINE; RETINOL; VACCINE;

ADAPTIVE IMMUNITY; CELLULAR IMMUNITY; CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG EFFECT; HEALTH PROGRAM; HETEROLOGOUS IMMUNITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFANCY; INFECTION; INFLAMMATION; INNATE IMMUNITY; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; VACCINATION;

FEMALE; HUMANS; MALE; SEX CHARACTERISTICS; VACCINES;

EID: 79952361446     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.071     Document Type: Conference Paper

References (62)

1. Aaby P., Knudsen K., Whittle H., Lisse I.M., Thaarup J., Poulsen A., et al. Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate. J Pediatr 1993, 122(6):904-908.
2. Aaby P., Samb B., Simondon F., Knudsen K., Seck A.M., Bennett J., et al. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal. Am J Epidemiol 1993, 138(9):746-755.
3. Benn C.S., Rodrigues A., Yazdanbakhsh M., Fisker A.B., Ravn H., Whittle H., et al. The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination. Vaccine 2009, 27(21):2891-2898.
4. Garly M.L., Jensen H., Martins C.L., Bale C., Balde M.A., Lisse I.M., et al. vaccination associated with higher female than male mortality in Guinea-bissau: an observational study. Pediatr Infect Dis J 2004, 23(12):1086-1092.
5. Rodrigues A., Fischer T.K., Valentiner-Branth P., Nielsen J., Steinsland H., Perch M., et al. Community cohort study of rotavirus and other enteropathogens: are routine vaccinations associated with sex-differential incidence rates?. Vaccine 2006, 24(22):4737-4746.
6. Stensballe L.G., Nante E., Jensen I.P., Kofoed P.E., Poulsen A., Jensen H., et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study. Vaccine 2005, 23(10):1251-1257.
7. Valentiner-Branth P., Perch M., Nielsen J., Steinsland H., Garly M.L., Fischer T.K., et al. Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diphtheria-tetanus-pertussis vaccinations. Vaccine 2007, 25(14):2733-2741.
8. Aaby P., Martins C.L., Garly M.L., Bale C., Anderson A., Rodrigues A., et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. Brit Med J 2010, 341:c6495.
9. Benn C.S., Fisker A.B., Napirna B.M., Roth A., Diness B.R., Lausch K.R., et al. Supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. Brit Med J 2010, 340:c1101.
10. Aaby P., Ibrahim S.A., Libman M.D., Jensen H. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa. Vaccine 2006, 24(15):2764-2771.
11. Aaby P., Jensen H., Rodrigues A., Garly M.L., Benn C.S., Lisse I.M., et al. Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. Int J Epidemiol 2004, 33(2):367-373.
12. Aaby P., Jensen H., Walraven G. Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia. Vaccine 2006, 24(22):4701-4708.
13. Benn C.S., Aaby P., Nielsen J., Binka F.N., Ross D.A. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana vitamin A supplementation trial. Am J Clin Nutr 2009, 90(3):629-639.
14. Aaby P., Vessari H., Nielsen J., Maleta K., Benn C.S., Jensen H., et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr Infect Dis J 2006, 25(8):721-727.
15. Aaby P., Jensen H., Samb B., Cisse B., Sodemann M., Jakobsen M., et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet 2003, 361(9376):2183-2188.
16. Aaby P., Jensen H., Gomes J., Fernandes M., Lisse I.M. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. Int J Epidemiol 2004, 33(2):374-380.
17. Velema J.P., Alihonou E.M., Gandaho T., Hounye F.H. Childhood mortality among users and non-users of primary health care in a rural west African community. Int J Epidemiol 1991, 20(2):474-479.
18. Holt E.A., Moulton L.H., Siberry G.K., Halsey N.A. Differential mortality by measles vaccine titer and sex. J Infect Dis 1993, 168(5):1087-1096.
19. Aaby P., Bhuiya A., Nahar L., Knudsen K., de Francisco A., Strong M. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. Int J Epidemiol 2003, 32(1):106-116.
20. Alexandroff A.B., Jackson A.M., O'Donnell M.A., James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999, 353(9165):1689-1694.
21. Farrington C.P., Firth M.J., Moulton L.H., Ravn H., Andersen P.K., Evans S. Epidemiological studies of the non-specific effects of vaccines. II. Methodological issues in the design and analysis of cohort studies. Trop Med Int Health 2009, 14(9):977-985.
22. Fine P.E., Williams T.N., Aaby P., Kallander K., Moulton L.H., Flanagan K.L., et al. Epidemiological studies of the 'non-specific effects' of vaccines: I-data collection in observational studies. Trop Med Int Health 2009, 14(9):969-976.
23. Shann F., Nohynek H., Scott J.A., Hesseling A., Flanagan K.L. Randomized trials to study the nonspecific effects of vaccines in children in low-income countries. Pediatr Infect Dis J 2010, 29(5):457-461.
24. Kahlke V., Dohm C., Mees T., Brotzmann K., Schreiber S., Schroder J. Early interleukin-10 treatment improves survival and enhances immune function only in males after hemorrhage and subsequent sepsis. Shock 2002, 18(1):24-28.
25. Merkel S.M., Alexander S., Zufall E., Oliver J.D., Huet-Hudson Y.M. Essential role for estrogen in protection against vibrio vulnificus-induced endotoxic shock. Infect Immun 2001, 69(10):6119-6122.
26. Klein S. Host factors mediating sex differences in viral infection. Gend Med 2005, 2(4):197-207.
27. Klein S.L. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 2000, 24(6):627-638.
28. Klein S.L., Pekosz A., Passaretti C., Anker M., Olukoya P. Sex, gender, and influenza 2010, World Health Organization, ISBN 9789241500111.
29. Meier A., Chang J.J., Chan E.S., Pollard R.B., Sudhu H.K., Kulkarni S., et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009, 15:955-959.
30. Klein S.L., Jedlicka A., Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 2010, 10(5):338-349.
31. McKee A.S., Munks M.W., Marrack P. How do adjuvants work? Important considerations for new generation adjuvants. Immunity 2007, 27(5):687-690.
32. Kanzler H., Barrat F.J., Hessel E.M., Coffman R.L. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007, 13(5):552-559.
33. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev 2007, 7(5):379-390.
34. Levy O., Zarember K.A., Roy R.M., Cywes C., Godowski P.J., Wessels M.R. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004, 173(7):4627-4634.
35. Yan S.R., Qing G., Byers D.M., Stadnyk A.W., Al-Hertani W., Bortolussi R. Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 2004, 72(3):1223-1229.
36. Marriott I., Bost K.L., Huet-Hudson Y.M. Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. J Reproduct Immunol 2006, 71(1):12-27.
37. Rettew J.A., Huet Y.M., Marriott I. Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo. Endocrinology 2009, 150(8):3877-3884.
38. Rettew J.A., Huet-Hudson Y.M., Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reproduct 2008, 78(3):432-437.
39. Goriely S., Vincart B., Stordeur P., Vekemans J., Willems F., Goldman M., et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001, 166(3):2141-2146.
40. Krampera M., Tavecchia L., Benedetti F., Nadali G., Pizzolo G. Intracellular cytokine profile of cord blood T-, and NK-cells and monocytes. Haematologica 2000, 85(7):675-679.
41. Smart J.M., Kemp A.S. Ontogeny of T-helper 1 and T-helper 2 cytokine production in childhood. Pediatr Allergy Immunol 2001, 12(4):181-187.
42. Vekemans J., Amedei A., Ota M.O., D'Elios M.M., Goetghebuer T., Ismaili J., et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 2001, 31(5):1531-1535.
43. Burl S., Adetifa J.U., Cox M., Touray E., Ota M.O., Marchant A., et al. vaccination from birth to 4 1/2 months of age reduces post-vaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol 2010, 185(4):2620-2628.
44. Ovsyannikova I.G., Reid K.C., Jacobson R.M., Oberg A.L., Klee G.G., Poland G.A. Cytokine production patterns and antibody response to measles vaccine. Vaccine 2003, 21(25-26):3946-3953.
45. Andersson A.M., Toppari J., Haavisto A.M., Petersen J.H., Simell T., Simell O., et al. Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metabol 1998, 83(2):675-681.
46. Winter J.S., Hughes I.A., Reyes F.I., Faiman C. Pituitary-gonadal relations in infancy: 2. Patterns of serum gonadal steroid concentrations in man from birth to two years of age. J Clin Endocrinol Metabol 1976, 42(4):679-686.
47. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev 2008, 8(9):737-744.
48. Savy M., Edmond K., Fine P.E., Hall A., Hennig B.J., Moore S.E., et al. Landscape analysis of interactions between nutrition and vaccine responses in children. J Nutr 2009, 139(11):2154S-2218S.
49. McKee A.S., Munks M.W., MacLeod M.K., Fleenor C.J., Van Rooijen N., Kappler J.W., et al. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 2009, 183(7):4403-4414.
50. Marrack P., McKee A.S., Munks M.W. Towards an understanding of the adjuvant action of aluminium. Nat Rev 2009, 9(4):287-293.
51. Mosca F., Tritto E., Muzzi A., Monaci E., Bagnoli F., Iavarone C., et al. Molecular and cellular signatures of human vaccine adjuvants. Proc Natl Acad Sci USA 2008, 105(30):10501-10506.
52. Pittman P.R. Aluminum-containing vaccine associated adverse events: role of route of administration and gender. Vaccine 2002, 20(Suppl. 3):S48-50.
53. Reif D.M., Motsinger-Reif A.A., McKinney B.A., Rock M.T., Crowe J.E., Moore J.H. Integrated analysis of genetic and proteomic data identifies biomarkers associated with adverse events following smallpox vaccination. Genes Immun 2009, 10(2):112-119.
54. Chen H.D., Fraire A.E., Joris I., Welsh R.M., Selin L.K. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 2003, 163(4):1341-1355.
55. Welsh R.M., Che J.W., Brehm M.A., Selin L.K. Heterologous immunity between viruses. Immunol Rev 2010, 235(1):244-266.
56. Page K.R., Scott A.L., Manabe Y.C. The expanding realm of heterologous immunity: friend or foe?. Cell Microbiol 2006, 8(2):185-196.
57. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009, 182(8):4499-4506.
58. Bager P., Westergaard T., Rostgaard K., Nielsen N.M., Melbye M., Aaby P. Smallpox vaccination and risk of allergy and asthma. J Allergy Clin Immunol 2003, 111(6):1227-1231.
59. Villumsen M., Sorup S., Jess T., Ravn H., Relander T., Baker J.L., et al. Risk of lymphoma and leukaemia after bacille Calmette-Guerin and smallpox vaccination: a Danish case-cohort study. Vaccine 2009, 27(49):6950-6958.
60. Putting gender on the agenda. Nature 2010;465(7299):665.
61. Kim A.M., Tingen C.M., Woodruff T.K. Sex bias in trials and treatment must end. Nature 2010, 465(7299):688-689.
62. Kawai K., Msamanga G., Manji K., Villamor E., Bosch R.J., Hertzmark E., et al. Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania. Brit J Nutr 2010, 103(12):1784-1791.